Golgi stress-induced transcriptional changes mediated by MAPK signaling and three ETS transcription factors regulate MCL1 splicing.
Golgi stress-induced transcriptional changes mediated by MAPK signaling and three ETS transcription factors regulate MCL1 splicing.
复制标题
DOI:
10.1091/mbc.e17-06-0418
复制
发表时间:
2018-01-01
影响因子:
3.3
通讯作者:
Reiling JH
中科院分区:
文献类型:
--
作者:
Baumann J;Ignashkova TI;Chirasani SR;Ramírez-Peinado S;Alborzinia H;Gendarme M;Kuhnigk K;Kramer V;Lindemann RK;Reiling JH
Transcriptomic profiling of cells treated with Golgi-disrupting compounds reveals that some target genes including several spliceosome components are controlled by ELK1, GABPA, and ETS1, the activity of which is regulated by MEK/ERK signaling. Furthermore, brefeldin A and golgicide A cause increased splicing of the proapoptotic MCL1-S isoform. The secretory pathway is a major determinant of cellular homoeostasis. While research into secretory stress signaling has so far mostly focused on the endoplasmic reticulum (ER), emerging data suggest that the Golgi itself serves as an important signaling hub capable of initiating stress responses. To systematically identify novel Golgi stress mediators, we performed a transcriptomic analysis of cells exposed to three different pharmacological compounds known to elicit Golgi fragmentation: brefeldin A, golgicide A, and monensin. Subsequent gene-set enrichment analysis revealed a significant contribution of the ETS family transcription factors ELK1, GABPA/B, and ETS1 to the control of gene expression following compound treatment. Induction of Golgi stress leads to a late activation of the ETS upstream kinases MEK1/2 and ERK1/2, resulting in enhanced ETS factor activity and the transcription of ETS family target genes related to spliceosome function and cell death induction via alternate MCL1 splicing. Further genetic analyses using loss-of-function and gain-of-function experiments suggest that these transcription factors operate in parallel.